Clinical Trial Update: Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rituximab and bortezomib for newly diagnosed acquired hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hemophilia

Drugs mentioned

• Bortezomib (bortezomib)
• Rituximab (rituximab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Acquired Hemophilia A | Phase 2 | Status: UNKNOWN